Home The Word Brain	My Amedeo FAQ Privacy About
	2049 Chinese The 20K Word Road to Mandarin Proficiency By B. S. Kamps et al.

Parkinson's Disease

Free Subscription Articles published in Neurobiol Dis Retrieve available abstracts of 175 articles: HTML format

Single Articles

June 2024
1. LEAVITT D, Alanazi FI, Al-Ozzi TM, Cohn M, et al
   Auditory oddball responses in the human subthalamic nucleus and substantia nigra pars reticulata.
   Neurobiol Dis. 2024;195:106490.
   PubMed     Abstract available
   
   
   May 2024
2. GULBERTI A, Schneider TR, Galindo-Leon EE, Heise M, et al
   Premotor cortical beta synchronization and the network neuromodulation of externally paced finger tapping in Parkinson's disease.
   Neurobiol Dis. 2024 May 11:106529. doi: 10.1016/j.nbd.2024.106529.
   PubMed     Abstract available
   
   
   
3. SHI D, Wu S, Zhuang C, Mao Y, et al
   Multimodal data fusion reveals functional and neurochemical correlates of Parkinson's disease.
   Neurobiol Dis. 2024 May 11:106527. doi: 10.1016/j.nbd.2024.106527.
   PubMed     Abstract available
   
   
   
4. ILIEVA NM, Hoffman EK, Ghalib MA, Greenamyre JT, et al
   LRRK2 kinase inhibition protects against Parkinson's disease-associated environmental toxicants.
   Neurobiol Dis. 2024 May 3:106522. doi: 10.1016/j.nbd.2024.106522.
   PubMed     Abstract available
   
   
   
5. HEMBACH S, Schmidt S, Orschmann T, Burtscher I, et al
   Engrailed 1 deficiency induces changes in ciliogenesis during human neuronal differentiation.
   Neurobiol Dis. 2024;194:106474.
   PubMed     Abstract available
   
   
   April 2024
6. GUO X, He S, Geng X, Yao P, et al
   Quantifying local field potential dynamics with amplitude and frequency stability between ON and OFF medication and stimulation in Parkinson's disease.
   Neurobiol Dis. 2024 Apr 27:106519. doi: 10.1016/j.nbd.2024.106519.
   PubMed     Abstract available
   
   
   
7. RURAK BK, Tan J, Rodrigues JP, Power BD, et al
   Cortico-cortical connectivity is influenced by levodopa in tremor-dominant Parkinson's disease.
   Neurobiol Dis. 2024;196:106518.
   PubMed     Abstract available
   
   
   
8. TREMBLAY C, Aslam S, Walker JE, Lorenzini I, et al
   RNA sequencing of olfactory bulb in Parkinson's disease reveals gene alterations associated with olfactory dysfunction.
   Neurobiol Dis. 2024 Apr 23:106514. doi: 10.1016/j.nbd.2024.106514.
   PubMed     Abstract available
   
   
   
9. BUOSO C, Seifert M, Lang M, Griffith CM, et al
   Dopamine?iron homeostasis interaction rescues mitochondrial fitness in Parkinson's disease.
   Neurobiol Dis. 2024 Apr 20:106506. doi: 10.1016/j.nbd.2024.106506.
   PubMed     Abstract available
   
   
   
10. TONG B, Ba Y, Li Z, Yang C, et al
    Targeting dysregulated lipid metabolism for the treatment of Alzheimer's disease and Parkinson's disease: Current advancements and future prospects.
    Neurobiol Dis. 2024 Apr 18:106505. doi: 10.1016/j.nbd.2024.106505.
    PubMed     Abstract available
    
    
    
11. JIAO LL, Dong HL, Liu MM, Wu PL, et al
    The potential roles of salivary biomarkers in neurodegenerative diseases.
    Neurobiol Dis. 2024;193:106442.
    PubMed     Abstract available
    
    
    March 2024
12. IOVINO L, Vander Zwaag J, Kaur G, Khakpour M, et al
    Investigation of microglial diversity in a LRRK2 G2019S mouse model of Parkinson's disease.
    Neurobiol Dis. 2024 Mar 23:106481. doi: 10.1016/j.nbd.2024.106481.
    PubMed     Abstract available
    
    
    
13. ZHOU C, You J, Guan X, Guo T, et al
    Microstructural alterations of the hypothalamus in Parkinson's disease and probable REM sleep behavior disorder.
    Neurobiol Dis. 2024 Mar 11:106472. doi: 10.1016/j.nbd.2024.106472.
    PubMed     Abstract available
    
    
    February 2024
14. HUANG YT, Chen YW, Lin TY, Chen JC, et al
    Suppression of presynaptic corticostriatal glutamate activity attenuates L-dopa-induced dyskinesia in 6-OHDA-lesioned Parkinson's disease mice.
    Neurobiol Dis. 2024;193:106452.
    PubMed     Abstract available
    
    
    
15. STOLL AC, Kemp CJ, Patterson JR, Howe JW, et al
    Neuroinflammatory gene expression profiles of reactive glia in the substantia nigra suggest a multidimensional immune response to alpha synuclein inclusions.
    Neurobiol Dis. 2024;191:106411.
    PubMed     Abstract available
    
    
    January 2024
16. IMARISIO A, Yahyavi I, Avenali M, Di Maio A, et al
    Blood D-serine levels correlate with aging and dopaminergic treatment in Parkinson's disease.
    Neurobiol Dis. 2024;192:106413.
    PubMed     Abstract available
    
    
    
17. WU C, Wu H, Zhou C, Guan X, et al
    Neurovascular coupling alteration in drug-naive Parkinson's disease: The underlying molecular mechanisms and levodopa's restoration effects.
    Neurobiol Dis. 2024 Jan 8:106406. doi: 10.1016/j.nbd.2024.106406.
    PubMed     Abstract available
    
    
    
18. SALIN P, Melon C, Chassain C, Gubellini P, et al
    Interhemispheric reactivity of the subthalamic nucleus sustains progressive dopamine neuron loss in asymmetrical parkinsonism.
    Neurobiol Dis. 2024;191:106398.
    PubMed     Abstract available
    
    
    December 2023
19. TRAN S, Heida TC, Heijs JJA, Al-Ozzi T, et al
    Subthalamic and pallidal neurons are modulated during externally cued movements in Parkinson's disease.
    Neurobiol Dis. 2023 Dec 20:106384. doi: 10.1016/j.nbd.2023.106384.
    PubMed     Abstract available
    
    
    
20. LIANG K, Li X, Guo Q, Ma J, et al
    Structural changes in the retina and serum HMGB1 levels are associated with decreased cognitive function in patients with Parkinson's disease.
    Neurobiol Dis. 2023;190:106379.
    PubMed     Abstract available
    
    
    
21. DI LAZZARO G, Picca A, Boldrini S, Bove F, et al
    Differential profiles of serum cytokines in Parkinson's disease according to disease duration.
    Neurobiol Dis. 2023 Dec 5:106371. doi: 10.1016/j.nbd.2023.106371.
    PubMed     Abstract available
    
    
    November 2023
22. TSHILENGE KT, Bons J, Aguirre CG, Geronimo-Olvera C, et al
    Proteomic analysis of X-linked dystonia parkinsonism disease striatal neurons reveals altered RNA metabolism and splicing.
    Neurobiol Dis. 2023 Nov 30:106367. doi: 10.1016/j.nbd.2023.106367.
    PubMed     Abstract available
    
    
    
23. TOFFOLI M, Chohan H, Mullin S, Jesuthasan A, et al
    Phenotypic effect of GBA1 variants in individuals with and without Parkinson's disease: The RAPSODI study.
    Neurobiol Dis. 2023 Nov 3:106343. doi: 10.1016/j.nbd.2023.106343.
    PubMed     Abstract available
    
    
    
24. HARVEY J, Pishva E, Chouliaras L, Lunnon K, et al
    Elucidating distinct molecular signatures of Lewy body dementias.
    Neurobiol Dis. 2023;188:106337.
    PubMed     Abstract available
    
    
    
25. TUBERT C, Zampese E, Pancani T, Tkatch T, et al
    Feed-forward metabotropic signaling by Cav1 Ca(2+) channels supports pacemaking in pedunculopontine cholinergic neurons.
    Neurobiol Dis. 2023;188:106328.
    PubMed     Abstract available
    
    
    
26. DUES DJ, Ma Y, Nguyen APT, Offerman AV, et al
    Formation of templated inclusions in a forebrain alpha-synuclein mouse model is independent of LRRK2.
    Neurobiol Dis. 2023;188:106338.
    PubMed     Abstract available
    
    
    October 2023
27. RIVAS-SANTISTEBAN R, Rico A, Munoz A, Rodriguez AI, et al
    Boolean analysis shows a high proportion of dopamine D(2) receptors interacting with adenosine A(2A) receptors in striatal medium spiny neurons of mouse and non-human primate models of Parkinson's disease.
    Neurobiol Dis. 2023 Oct 31:106341. doi: 10.1016/j.nbd.2023.106341.
    PubMed     Abstract available
    
    
    
28. CHEN L, Sun J, Gao L, Wang J, et al
    Dysconnectivity of the parafascicular nucleus in Parkinson's disease: A dynamic causal modeling analysis.
    Neurobiol Dis. 2023;188:106335.
    PubMed     Abstract available
    
    
    
29. LI T, Liu T, Zhang J, Ma Y, et al
    Neurovascular coupling dysfunction of visual network organization in Parkinson's disease.
    Neurobiol Dis. 2023;188:106323.
    PubMed     Abstract available
    
    
    
30. MAPLE-GRODEM J, Ushakova A, Pedersen KF, Tysnes OB, et al
    Identification of diagnostic and prognostic biomarkers of PD using a multiplex proteomics approach.
    Neurobiol Dis. 2023;186:106281.
    PubMed     Abstract available
    
    
    
31. SCHAFFNER SL, Wassouf Z, Hentrich T, Nuesch-Germano M, et al
    Distinct impacts of alpha-synuclein overexpression on the hippocampal epigenome of mice in standard and enriched environments.
    Neurobiol Dis. 2023;186:106274.
    PubMed     Abstract available
    
    
    September 2023
32. DE FABREGUES O, Selles M, Ramos-Vicente D, Roch G, et al
    Relevance of tissue-resident memory CD8 T cells in the onset of Parkinson's disease and examination of its possible etiologies: infectious or autoimmune?
    Neurobiol Dis. 2023 Sep 21:106308. doi: 10.1016/j.nbd.2023.106308.
    PubMed     Abstract available
    
    
    
33. TRINH D, Israwi AR, Brar H, Villafuerte JEA, et al
    Parkinson's disease pathology is directly correlated to SIRT3 in human subjects and animal models: Implications for AAV.SIRT3-myc as a disease-modifying therapy.
    Neurobiol Dis. 2023 Sep 11:106287. doi: 10.1016/j.nbd.2023.106287.
    PubMed     Abstract available
    
    
    August 2023
34. GRONLIER E, Volle J, Coizet V, Paccard A, et al
    Evoked responses to single pulse electrical stimulation reveal impaired striatal excitability in a rat model of Parkinson's disease.
    Neurobiol Dis. 2023 Aug 19:106266. doi: 10.1016/j.nbd.2023.106266.
    PubMed     Abstract available
    
    
    
35. GAN C, Ji M, Sun H, Cao X, et al
    Dynamic functional connectivity reveals hyper-connected pattern and abnormal variability in freezing of gait of Parkinson's disease.
    Neurobiol Dis. 2023;185:106265.
    PubMed     Abstract available
    
    
    
36. REN J, Yan L, Zhou H, Pan C, et al
    Unraveling neurotransmitter changes in de novo GBA-related and idiopathic Parkinson's disease.
    Neurobiol Dis. 2023 Aug 7:106254. doi: 10.1016/j.nbd.2023.106254.
    PubMed     Abstract available
    
    
    
37. DUMONT M, Agostinis A, Singh K, Swan E, et al
    Sex representation in neurodegenerative and psychiatric disorders' preclinical and clinical studies.
    Neurobiol Dis. 2023;184:106214.
    PubMed     Abstract available
    
    
    
38. BHATIA TN, Jamenis AS, Abbas M, Clark RN, et al
    A 14-day pulse of PLX5622 modifies alpha-synucleinopathy in preformed fibril-infused aged mice of both sexes.
    Neurobiol Dis. 2023;184:106196.
    PubMed     Abstract available
    
    
    July 2023
39. CROCKETT RA, Wilkins KB, Aditham S, Bronte-Stewart HM, et al
    No laughing white matter: Reduced integrity of the cortical cholinergic pathways in Parkinson's disease-related cognitive impairment.
    Neurobiol Dis. 2023 Jul 29:106243. doi: 10.1016/j.nbd.2023.106243.
    PubMed     Abstract available
    
    
    
40. URSO D, Batzu L, Logroscino G, Chaudhuri KR, et al
    Neurofilament light predicts worse nonmotor symptoms and depression in Parkinson's disease.
    Neurobiol Dis. 2023 Jul 25:106237. doi: 10.1016/j.nbd.2023.106237.
    PubMed     Abstract available
    
    
    
41. AVANTAGGIATO F, Farokhniaee A, Bandini A, Palmisano C, et al
    Intelligibility of speech in Parkinson's disease relies on anatomically segregated subthalamic beta oscillations.
    Neurobiol Dis. 2023 Jul 25:106239. doi: 10.1016/j.nbd.2023.106239.
    PubMed     Abstract available
    
    
    
42. WANG Y, Xia Y, Kou L, Yin S, et al
    Astrocyte-to-neuron reprogramming and crosstalk in the treatment of Parkinson's disease.
    Neurobiol Dis. 2023 Jul 9:106224. doi: 10.1016/j.nbd.2023.106224.
    PubMed     Abstract available
    
    
    
43. LEGAZ A, Prado P, Moguilner S, Baez S, et al
    Social and non-social working memory in neurodegeneration.
    Neurobiol Dis. 2023;183:106171.
    PubMed     Abstract available
    
    
    June 2023
44. WU H, Wu C, Qin J, Zhou C, et al
    Functional connectome predicting individual gait function and its relationship with molecular architecture in Parkinson's disease.
    Neurobiol Dis. 2023;184:106216.
    PubMed     Abstract available
    
    
    
45. DI MAIO A, Nuzzo T, Gilio L, Serra M, et al
    Homeostasis of serine enantiomers is disrupted in the post-mortem caudate putamen and cerebrospinal fluid of living Parkinson's disease patients.
    Neurobiol Dis. 2023 Jun 17:106203. doi: 10.1016/j.nbd.2023.106203.
    PubMed     Abstract available
    
    
    
46. BATZU L, Urso D, Grothe MJ, Vereb D, et al
    Increased basal forebrain volumes could prevent cognitive decline in LRRK2 Parkinson's disease.
    Neurobiol Dis. 2023 Jun 5:106182. doi: 10.1016/j.nbd.2023.106182.
    PubMed     Abstract available
    
    
    
47. ZHONG M, Wang Y, Lin G, Liao FF, et al
    Dopamine-independent development and maintenance of mouse striatal medium spiny neuron dendritic spines.
    Neurobiol Dis. 2023;181:106096.
    PubMed     Abstract available
    
    
    May 2023
48. LUCHETTI S, Liere P, Pianos A, Verwer RWH, et al
    Disease stage-dependent changes in brain levels and neuroprotective effects of neuroactive steroids in Parkinson's disease.
    Neurobiol Dis. 2023 May 29:106169. doi: 10.1016/j.nbd.2023.106169.
    PubMed     Abstract available
    
    
    
49. YIN Z, Jiang Y, Merk T, Neumann WJ, et al
    Pallidal activities during sleep and sleep decoding in dystonia, Huntington's, and Parkinson's disease.
    Neurobiol Dis. 2023 May 3:106143. doi: 10.1016/j.nbd.2023.106143.
    PubMed     Abstract available
    
    
    
50. FAYARD A, Fenyi A, Lavisse S, Dovero S, et al
    Functional and neuropathological changes induced by injection of distinct alpha-synuclein strains: A pilot study in non-human primates.
    Neurobiol Dis. 2023;180:106086.
    PubMed     Abstract available
    
    
    
51. CHEN Z, Reynolds RH, Pardinas AF, Gagliano Taliun SA, et al
    The contribution of Neanderthal introgression and natural selection to neurodegenerative diseases.
    Neurobiol Dis. 2023;180:106082.
    PubMed     Abstract available
    
    
    April 2023
52. GUERRA A, Colella D, Cannavacciuolo A, Giangrosso M, et al
    Short-term plasticity of the motor cortex compensates for bradykinesia in Parkinson's disease.
    Neurobiol Dis. 2023;182:106137.
    PubMed     Abstract available
    
    
    
53. HAYLEY S, Vahid-Ansari F, Sun H, Albert PR, et al
    Mood disturbances in Parkinson's disease: From prodromal origins to application of animal models.
    Neurobiol Dis. 2023 Apr 8:106115. doi: 10.1016/j.nbd.2023.106115.
    PubMed     Abstract available
    
    
    
54. SASIKUMAR S, Sorrento G, Lang AE, Strafella AP, et al
    Cognition affects gait adaptation after split-belt treadmill training in Parkinson's disease.
    Neurobiol Dis. 2023 Apr 3:106109. doi: 10.1016/j.nbd.2023.106109.
    PubMed     Abstract available
    
    
    March 2023
55. CAULFIELD ME, Vander Werp MJ, Stancati JA, Collier TJ, et al
    Downregulation of striatal Ca(V)1.3 inhibits the escalation of levodopa-induced dyskinesia in male and female parkinsonian rats of advanced age.
    Neurobiol Dis. 2023 Mar 29:106111. doi: 10.1016/j.nbd.2023.106111.
    PubMed     Abstract available
    
    
    
56. HUANG Q, Chen C, Chen W, Cai C, et al
    Cell type- and region-specific translatomes in an MPTP mouse model of Parkinson's disease.
    Neurobiol Dis. 2023;180:106105.
    PubMed     Abstract available
    
    
    
57. TAN S, Zhou C, Wen J, Duanmu X, et al
    Presence but not the timing of onset of REM sleep behavior disorder distinguishes evolution patterns in Parkinson's disease.
    Neurobiol Dis. 2023;180:106084.
    PubMed     Abstract available
    
    
    
58. PORRINI V, Pilotto A, Vezzoli M, Lanzillotta A, et al
    NF-kappaB/c-Rel DNA-binding is reduced in substantia nigra and peripheral blood mononuclear cells of Parkinson's disease patients.
    Neurobiol Dis. 2023 Mar 7:106067. doi: 10.1016/j.nbd.2023.106067.
    PubMed     Abstract available
    
    
    
59. WIEST C, He S, Duchet B, Pogosyan A, et al
    Evoked resonant neural activity in subthalamic local field potentials reflects basal ganglia network dynamics.
    Neurobiol Dis. 2023;178:106019.
    PubMed     Abstract available
    
    
    
60. LIN S, Leitao ADG, Fang S, Gu Y, et al
    Overexpression of alpha synuclein disrupts APP and Endolysosomal axonal trafficking in a mouse model of synucleinopathy.
    Neurobiol Dis. 2023;178:106010.
    PubMed     Abstract available
    
    
    February 2023
61. MCKAY JL, Nye J, Goldstein FC, Sommerfeld B, et al
    Levodopa responsive freezing of gait is associated with reduced norepinephrine transporter binding in Parkinson's disease.
    Neurobiol Dis. 2023 Feb 20:106048. doi: 10.1016/j.nbd.2023.106048.
    PubMed     Abstract available
    
    
    January 2023
62. ABDI IY, Bartl M, Dakna M, Abdesselem H, et al
    Cross-sectional proteomic expression in Parkinson's disease-related proteins in drug-naive patients vs healthy controls with longitudinal clinical follow-up.
    Neurobiol Dis. 2023 Jan 9:105997. doi: 10.1016/j.nbd.2023.105997.
    PubMed     Abstract available
    
    
    
63. OUTEIRO TF, El-Agnaf OM
    The immune system in Parkinson's disease: From biology to diagnosis and therapeutic targets.
    Neurobiol Dis. 2023 Jan 7:105995. doi: 10.1016/j.nbd.2023.105995.
    PubMed    
    
    
    
64. MARTEL AC, Galvan A
    Corrigendum to: "Connectivity of the Corticostriatal and Thalamostriatal Systems in Normal and Parkinsonian States: An Update" Neurobiology of Disease 174: 105878.
    Neurobiol Dis. 2023 Jan 2:105985. doi: 10.1016/j.nbd.2022.105985.
    PubMed    
    
    
    
65. ESTAUN-PANZANO J, Arotcarena ML, Bezard E
    Monitoring alpha-synuclein aggregation.
    Neurobiol Dis. 2023;176:105966.
    PubMed     Abstract available
    
    
    
66. DE LAZZARI F, Agostini F, Plotegher N, Sandre M, et al
    DJ-1 promotes energy balance by regulating both mitochondrial and autophagic homeostasis.
    Neurobiol Dis. 2023;176:105941.
    PubMed     Abstract available
    
    
    
67. CASTELA I, Casado-Polanco R, Rubio YV, da Silva JA, et al
    Selective activation of striatal indirect pathway suppresses levodopa induced-dyskinesias.
    Neurobiol Dis. 2023;176:105930.
    PubMed     Abstract available
    
    
    December 2022
68. LEWITT PA, Li J, Wu KH, Lu M, et al
    Diagnostic metabolomic profiling of Parkinson's disease biospecimens.
    Neurobiol Dis. 2022 Dec 20:105962. doi: 10.1016/j.nbd.2022.105962.
    PubMed     Abstract available
    
    
    
69. BRENDZA R, Gao X, Stark KL, Lin H, et al
    Anti-alpha-synuclein c-terminal antibodies block PFF uptake and accumulation of phospho-synuclein in preclinical models of Parkinson's disease.
    Neurobiol Dis. 2022 Dec 16:105969. doi: 10.1016/j.nbd.2022.105969.
    PubMed     Abstract available
    
    
    
70. LIPARI N, Centner A, Glinski J, Cohen S, et al
    Characterizing the relationship between L-DOPA-induced-dyskinesia and psychosis-like behaviors in a bilateral rat model of Parkinson's disease.
    Neurobiol Dis. 2022;176:105965.
    PubMed     Abstract available
    
    
    
71. VERMA AK, Yu Y, Acosta-Lenis SF, Havel T, et al
    Parkinsonian daytime sleep-wake classification using deep brain stimulation lead recordings.
    Neurobiol Dis. 2022 Dec 12:105963. doi: 10.1016/j.nbd.2022.105963.
    PubMed     Abstract available
    
    
    
72. MELONI M, Agliardi C, Guerini FR, Zanzottera M, et al
    Oligomeric alpha-synuclein and tau aggregates in NDEVs differentiate Parkinson's disease from atypical parkinsonisms.
    Neurobiol Dis. 2022 Dec 5:105947. doi: 10.1016/j.nbd.2022.105947.
    PubMed     Abstract available
    
    
    
73. GOPINATH A, Mackie PM, Phan LT, Tansey MG, et al
    The complex role of inflammation and gliotransmitters in Parkinson's disease.
    Neurobiol Dis. 2022 Dec 2:105940. doi: 10.1016/j.nbd.2022.105940.
    PubMed     Abstract available
    
    
    
74. GAERTNER Z, Azcorra M, Dombeck DA, Awatramani R, et al
    Molecular heterogeneity in the substantia nigra: A roadmap for understanding PD motor pathophysiology.
    Neurobiol Dis. 2022;175:105925.
    PubMed     Abstract available
    
    
    
75. TAI CH, Tseng SH
    Cerebellar deep brain stimulation for movement disorders.
    Neurobiol Dis. 2022;175:105899.
    PubMed     Abstract available
    
    
    November 2022
76. WISE RM, Wagener A, Fietzek UM, Klopstock T, et al
    Interactions of dopamine, iron, and alpha-synuclein linked to dopaminergic neuron vulnerability in Parkinson's disease and Neurodegeneration with Brain Iron Accumulation disorders.
    Neurobiol Dis. 2022;175:105920.
    PubMed     Abstract available
    
    
    
77. SARKAR S
    Microglial ion channels: Key players in non-cell autonomous neurodegeneration.
    Neurobiol Dis. 2022;174:105861.
    PubMed     Abstract available
    
    
    October 2022
78. CHO E, Kim K, Kim H, Cho SR, et al
    Reelin protects against pathological alpha-synuclein accumulation and dopaminergic neurodegeneration after environmental enrichment in Parkinson's disease.
    Neurobiol Dis. 2022 Oct 18:105898. doi: 10.1016/j.nbd.2022.105898.
    PubMed     Abstract available
    
    
    
79. PUIGROS M, Calderon A, Perez-Soriano A, de Dios C, et al
    Cell-free mitochondrial DNA deletions in idiopathic, but not LRRK2, Parkinson's disease.
    Neurobiol Dis. 2022;174:105885.
    PubMed     Abstract available
    
    
    
80. RYU DW, Yoo SW, Oh YS, Lee KS, et al
    Comparison of disease progression between brain-predominant Parkinson's disease versus Parkinson's disease with body-involvement phenotypes.
    Neurobiol Dis. 2022;174:105883.
    PubMed     Abstract available
    
    
    
81. EVANS RC
    Dendritic involvement in inhibition and disinhibition of vulnerable dopaminergic neurons in healthy and pathological conditions.
    Neurobiol Dis. 2022;172:105815.
    PubMed     Abstract available
    
    
    September 2022
82. MARTEL AC, Galvan A
    Connectivity of the corticostriatal and thalamostriatal systems in normal and parkinsonian states: An update.
    Neurobiol Dis. 2022;174:105878.
    PubMed     Abstract available
    
    
    
83. RUF WP, Palmer A, Dorfer L, Wiesner D, et al
    Thoracic trauma promotes alpha-Synuclein oligomerization in murine Parkinson's disease.
    Neurobiol Dis. 2022 Sep 23:105877. doi: 10.1016/j.nbd.2022.105877.
    PubMed     Abstract available
    
    
    
84. ZANG NAM, Schneider M, Weiss D
    Cortical mechanisms of movement recovery after freezing in Parkinson's disease.
    Neurobiol Dis. 2022;174:105871.
    PubMed     Abstract available
    
    
    
85. STOLL AC, Sortwell CE
    Leveraging the preformed fibril model to distinguish between alpha-synuclein inclusion- and nigrostriatal degeneration-associated immunogenicity.
    Neurobiol Dis. 2022;171:105804.
    PubMed     Abstract available
    
    
    August 2022
86. IMBRIANI P, Martella G, Bonsi P, Pisani A, et al
    Oxidative stress and synaptic dysfunction in rodent models of Parkinson's disease.
    Neurobiol Dis. 2022 Aug 22:105851. doi: 10.1016/j.nbd.2022.105851.
    PubMed     Abstract available
    
    
    
87. OUN A, Sabogal-Guaqueta AM, Galuh S, Alexander A, et al
    The multifaceted role of LRRK2 in Parkinson's disease: From human iPSC to organoids.
    Neurobiol Dis. 2022 Aug 10:105837. doi: 10.1016/j.nbd.2022.105837.
    PubMed     Abstract available
    
    
    
88. WILLIAMS ET, Chen X, Otero PA, Moore DJ, et al
    Understanding the contributions of VPS35 and the retromer in neurodegenerative disease.
    Neurobiol Dis. 2022;170:105768.
    PubMed     Abstract available
    
    
    
89. ERDMAN HB, Kornilov E, Kahana E, Zarchi O, et al
    Asleep DBS under ketamine sedation: Proof of concept.
    Neurobiol Dis. 2022;170:105747.
    PubMed     Abstract available
    
    
    July 2022
90. BICHSEL O, Stieglitz L, Oertel M, Baumann C, et al
    The modulatory effect of self-paced and cued motor execution on subthalamic beta-bursts in Parkinson's disease: Evidence from deep brain recordings in humans.
    Neurobiol Dis. 2022;172:105818.
    PubMed     Abstract available
    
    
    
91. TIAN Y, Pan L, Yuan X, Xiong M, et al
    7,8-Dihydroxyflavone ameliorates mitochondrial impairment and motor dysfunction in the alpha-synuclein 1-103 transgenic mice.
    Neurobiol Dis. 2022;169:105736.
    PubMed     Abstract available
    
    
    
92. RUSSO I, Bubacco L, Greggio E
    LRRK2 as a target for modulating immune system responses.
    Neurobiol Dis. 2022;169:105724.
    PubMed     Abstract available
    
    
    
93. BURMEISTER AR, Gordevicius J, Paul EN, Houck C, et al
    Maternal Herpesviridae infection during pregnancy alters midbrain dopaminergic signatures in adult offspring.
    Neurobiol Dis. 2022;169:105720.
    PubMed     Abstract available
    
    
    
94. PAMIES D, Wiersma D, Katt ME, Zhao L, et al
    Human IPSC 3D brain model as a tool to study chemical-induced dopaminergic neuronal toxicity.
    Neurobiol Dis. 2022;169:105719.
    PubMed     Abstract available
    
    
    June 2022
95. TSAFARAS G, Baekelandt V
    The role of LRRK2 in the periphery: link with Parkinson's disease and inflammatory diseases.
    Neurobiol Dis. 2022 Jun 30:105806. doi: 10.1016/j.nbd.2022.105806.
    PubMed     Abstract available
    
    
    
96. O'HANLON ME, Tweedy C, Scialo F, Bass R, et al
    Mitochondrial electron transport chain defects modify Parkinson's disease phenotypes in a Drosophila model.
    Neurobiol Dis. 2022 Jun 25:105803. doi: 10.1016/j.nbd.2022.105803.
    PubMed     Abstract available
    
    
    
97. MANTIA K, Kostas V, Katerina M
    The promise of the TGF-beta superfamily as a therapeutic target for Parkinson's disease.
    Neurobiol Dis. 2022 Jun 25:105805. doi: 10.1016/j.nbd.2022.105805.
    PubMed     Abstract available
    
    
    
98. RAUSCHENBERGER L, Behnke J, Grotemeyer A, Knorr S, et al
    Age-dependent neurodegeneration and neuroinflammation in a genetic A30P/A53T double-mutated alpha-synuclein mouse model of Parkinson's disease.
    Neurobiol Dis. 2022 Jun 21:105798. doi: 10.1016/j.nbd.2022.105798.
    PubMed     Abstract available
    
    
    
99. KIM J, Lee J, Kim E, Choi JH, et al
    Dopamine depletion can be predicted by the aperiodic component of subthalamic local field potentials.
    Neurobiol Dis. 2022;168:105692.
    PubMed     Abstract available
    
    
    May 2022
100. VOIGT RM, Wang Z, Brown JM, Engen PA, et al
     Gut microbial metabolites in Parkinson's disease: Association with lifestyle, disease characteristics, and treatment status.
     Neurobiol Dis. 2022 May 30:105780. doi: 10.1016/j.nbd.2022.105780.
     PubMed     Abstract available
     
     
     
101. SONG B, Feldmann JW, Cao S, Feitosa M, et al
     A Pitx3-deficient developmental mouse model for fine motor, olfactory, and gastrointestinal symptoms of Parkinson's disease.
     Neurobiol Dis. 2022 May 27:105777. doi: 10.1016/j.nbd.2022.105777.
     PubMed     Abstract available
     
     
     
102. ABDI IY, Ghanem SS, El-Agnaf OM
     Immune-related biomarkers for Parkinson's disease.
     Neurobiol Dis. 2022;170:105771.
     PubMed     Abstract available
     
     
     
103. KEENEY MT, Hoffman EK, Farmer K, Bodle CR, et al
     NADPH oxidase 2 activity in Parkinson's disease.
     Neurobiol Dis. 2022 May 13:105754. doi: 10.1016/j.nbd.2022.105754.
     PubMed     Abstract available
     
     
     
104. BARTL M, Xylaki M, Bahr M, Weber S, et al
     Evidence for immune system alterations in peripheral biological fluids in Parkinson's disease.
     Neurobiol Dis. 2022 May 2:105744. doi: 10.1016/j.nbd.2022.105744.
     PubMed     Abstract available
     
     
     
105. IZCO M, Carlos E, Alvarez-Erviti L
     Impact of endolysosomal dysfunction upon exosomes in neurodegenerative diseases.
     Neurobiol Dis. 2022;166:105651.
     PubMed     Abstract available
     
     
     April 2022
106. MAMAIS A, Kaganovich A, Harvey K
     Convergence of signalling pathways in innate immune responses and genetic forms of Parkinson's disease.
     Neurobiol Dis. 2022;169:105721.
     PubMed     Abstract available
     
     
     March 2022
107. CAMPANELLI F, Natale G, Marino G, Ghiglieri V, et al
     Striatal glutamatergic hyperactivity in Parkinson's disease.
     Neurobiol Dis. 2022 Mar 18:105697. doi: 10.1016/j.nbd.2022.105697.
     PubMed     Abstract available
     
     
     
108. WEISS F, Labrador-Garrido A, Dzamko N, Halliday G, et al
     Immune responses in the Parkinson's disease brain.
     Neurobiol Dis. 2022;168:105700.
     PubMed     Abstract available
     
     
     
109. HENDERSON MX, Henrich MT, Geibl FF, Oertel WH, et al
     The roles of connectivity and neuronal phenotype in determining the pattern of alpha-synuclein pathology in Parkinson's disease.
     Neurobiol Dis. 2022 Mar 10:105687. doi: 10.1016/j.nbd.2022.105687.
     PubMed     Abstract available
     
     
     
110. SHEN W, Zhai S, Surmeier DJ
     Striatal synaptic adaptations in Parkinson's disease.
     Neurobiol Dis. 2022 Mar 7:105686. doi: 10.1016/j.nbd.2022.105686.
     PubMed     Abstract available
     
     
     
111. COUSINEAU J, Plateau V, Baufreton J, Le Bon-Jego M, et al
     Dopaminergic modulation of primary motor cortex: From cellular and synaptic mechanisms underlying motor learning to cognitive symptoms in Parkinson's disease.
     Neurobiol Dis. 2022 Mar 1:105674. doi: 10.1016/j.nbd.2022.105674.
     PubMed     Abstract available
     
     
     February 2022
112. MOLINET-DRONDA F, Blesa J, Del Rey NL, Juri C, et al
     Cerebral metabolic pattern associated with progressive parkinsonism in non-human primates reveals early cortical hypometabolism.
     Neurobiol Dis. 2022;167:105669.
     PubMed     Abstract available
     
     
     
113. BOCCALINI C, Carli G, Pilotto A, Padovani A, et al
     Gender differences in dopaminergic system dysfunction in de novo Parkinson's disease clinical subtypes.
     Neurobiol Dis. 2022;167:105668.
     PubMed     Abstract available
     
     
     
114. GEGG ME, Menozzi E, Schapira AHV
     Glucocerebrosidase-associated Parkinson disease: Pathogenic mechanisms and potential drug treatments.
     Neurobiol Dis. 2022;166:105663.
     PubMed     Abstract available
     
     
     
115. KASEN A, Houck C, Burmeister AR, Sha Q, et al
     Upregulation of alpha-synuclein following immune activation: Possible trigger of Parkinson's disease.
     Neurobiol Dis. 2022 Feb 7:105654. doi: 10.1016/j.nbd.2022.105654.
     PubMed     Abstract available
     
     
     January 2022
116. HORSAGER J, Knudsen K, Sommerauer M
     Clinical and imaging evidence of brain-first and body-first Parkinson's disease.
     Neurobiol Dis. 2022 Jan 11:105626. doi: 10.1016/j.nbd.2022.105626.
     PubMed     Abstract available
     
     
     
117. WOERMAN AL, Tamguney G
     Body-first Parkinson's disease and variant Creutzfeldt-Jakob disease - similar or different?
     Neurobiol Dis. 2022 Jan 10:105625. doi: 10.1016/j.nbd.2022.105625.
     PubMed     Abstract available
     
     
     December 2021
118. LI J, Chen L, Qin Q, Wang D, et al
     Upregulated hexokinase 2 expression induces the apoptosis of dopaminergic neurons by promoting lactate production in Parkinson's disease.
     Neurobiol Dis. 2021;163:105605.
     PubMed     Abstract available
     
     
     
119. CHEN H, Wang K, Scheperjans F, Killinger B, et al
     Environmental triggers of Parkinson's disease - Implications of the Braak and dual-hit hypotheses.
     Neurobiol Dis. 2021;163:105601.
     PubMed     Abstract available
     
     
     
120. VAN DEN BERGE N, Ulusoy A
     Animal models of brain-first and body-first Parkinson's disease.
     Neurobiol Dis. 2021;163:105599.
     PubMed     Abstract available
     
     
     
121. SCHILDER BM, Navarro E, Raj T
     Multi-omic insights into Parkinson's Disease: From genetic associations to functional mechanisms.
     Neurobiol Dis. 2021 Dec 3:105580. doi: 10.1016/j.nbd.2021.105580.
     PubMed     Abstract available
     
     
     
122. NOVELLO S, Mercatelli D, Albanese F, Domenicale C, et al
     In vivo susceptibility to energy failure parkinsonism and LRRK2 kinase activity.
     Neurobiol Dis. 2021 Dec 3:105579. doi: 10.1016/j.nbd.2021.105579.
     PubMed     Abstract available
     
     
     
123. BORGHAMMER P, Horsager J, Andersen K, Van Den Berge N, et al
     Neuropathological evidence of body-first vs. brain-first Lewy body disease.
     Neurobiol Dis. 2021;161:105557.
     PubMed     Abstract available
     
     
     November 2021
124. HANG L, Wang Z, Foo ASC, Goh GWY, et al
     Conditional disruption of AMP kinase in dopaminergic neurons promotes Parkinson's disease-associated phenotypes in vivo.
     Neurobiol Dis. 2021;161:105560.
     PubMed     Abstract available
     
     
     
125. NORDSTROM E, Eriksson F, Sigvardson J, Johannesson M, et al
     ABBV-0805, a novel antibody selective for soluble aggregated alpha-synuclein, prolongs lifespan and prevents buildup of alpha-synuclein pathology in mouse models of Parkinson's disease.
     Neurobiol Dis. 2021 Nov 1:105543. doi: 10.1016/j.nbd.2021.105543.
     PubMed     Abstract available
     
     
     
126. FERRER-RAVENTOS P, Beyer K
     Alternative platelet activation pathways and their role in neurodegenerative diseases.
     Neurobiol Dis. 2021;159:105512.
     PubMed     Abstract available
     
     
     
127. JOHNSON ME, Bergkvist L, Stetzik L, Steiner JA, et al
     Heterozygous GBA D409V and ATP13a2 mutations do not exacerbate pathological alpha-synuclein spread in the prodromal preformed fibrils model in young mice.
     Neurobiol Dis. 2021;159:105513.
     PubMed     Abstract available
     
     
     
128. COSDEN M, Jinn S, Yao L, Gretzula CA, et al
     A novel glucosylceramide synthase inhibitor attenuates alpha synuclein pathology and lysosomal dysfunction in preclinical models of synucleinopathy.
     Neurobiol Dis. 2021;159:105507.
     PubMed     Abstract available
     
     
     
129. BRENDZA R, Lin H, Stark K, Foreman O, et al
     Genetic ablation of Gpnmb does not alter synuclein-related pathology.
     Neurobiol Dis. 2021;159:105494.
     PubMed     Abstract available
     
     
     
130. ALBANESE F, Mercatelli D, Finetti L, Lamonaca G, et al
     Constitutive silencing of LRRK2 kinase activity leads to early glucocerebrosidase deregulation and late impairment of autophagy in vivo.
     Neurobiol Dis. 2021;159:105487.
     PubMed     Abstract available
     
     
     October 2021
131. HU S, Tan J, Qin L, Lv L, et al
     Molecular chaperones and Parkinson's disease.
     Neurobiol Dis. 2021;160:105527.
     PubMed     Abstract available
     
     
     August 2021
132. ALANAZI FI, Al-Ozzi T, Kalia SK, Hodaie M, et al
     Neurophysiological responses of globus pallidus internus during the auditory oddball task in Parkinson's disease.
     Neurobiol Dis. 2021 Aug 27:105490. doi: 10.1016/j.nbd.2021.105490.
     PubMed     Abstract available
     
     
     
133. TORRES ERS, Stanojlovic M, Zelikowsky M, Bonsberger J, et al
     Alpha-synuclein pathology, microgliosis, and parvalbumin neuron loss in the amygdala associated with enhanced fear in the Thy1-aSyn model of Parkinson's disease.
     Neurobiol Dis. 2021;158:105478.
     PubMed     Abstract available
     
     
     
134. ARKAN S, Ljungberg M, Kirik D, Hansen C, et al
     DNAJB6 suppresses alpha-synuclein induced pathology in an animal model of Parkinson's disease.
     Neurobiol Dis. 2021 Aug 11:105477. doi: 10.1016/j.nbd.2021.105477.
     PubMed     Abstract available
     
     
     
135. OLSEN AL, Feany MB
     Parkinson's disease risk genes act in glia to control neuronal alpha-synuclein toxicity.
     Neurobiol Dis. 2021 Aug 11:105482. doi: 10.1016/j.nbd.2021.105482.
     PubMed     Abstract available
     
     
     
136. RODICHKIN AN, Edler MK, McGlothan JL, Guilarte TR, et al
     Behavioral and neurochemical studies of inherited manganese-induced dystonia-parkinsonism in Slc39a14-knockout mice.
     Neurobiol Dis. 2021 Aug 3:105467. doi: 10.1016/j.nbd.2021.105467.
     PubMed     Abstract available
     
     
     July 2021
137. KAKUSA B, Huang Y, Barbosa DAN, Feng A, et al
     Anticipatory human subthalamic area beta-band power responses to dissociable tastes correlate with weight gain.
     Neurobiol Dis. 2021;154:105348.
     PubMed     Abstract available
     
     
     June 2021
138. ANDREOLI L, Abbaszadeh M, Cao X, Cenci MA, et al
     Distinct patterns of dyskinetic and dystonic features following D1 or D2 receptor stimulation in a mouse model of parkinsonism.
     Neurobiol Dis. 2021 Jun 18:105429. doi: 10.1016/j.nbd.2021.105429.
     PubMed     Abstract available
     
     
     May 2021
139. FAUSER M, Ricken M, Markert F, Weis N, et al
     Subthalamic nucleus deep brain stimulation induces sustained neurorestoration in the mesolimbic dopaminergic system in a Parkinson's disease model.
     Neurobiol Dis. 2021 May 24:105404. doi: 10.1016/j.nbd.2021.105404.
     PubMed     Abstract available
     
     
     
140. TOMKINS JE, Manzoni C
     Advances in protein-protein interaction network analysis for Parkinson's disease.
     Neurobiol Dis. 2021;155:105395.
     PubMed     Abstract available
     
     
     
141. BRAZHNIK E, Novikov N, McCoy AJ, Ilieva NM, et al
     Early decreases in cortical mid-gamma peaks coincide with the onset of motor deficits and precede exaggerated beta build-up in rat models for Parkinson's disease.
     Neurobiol Dis. 2021 May 14:105393. doi: 10.1016/j.nbd.2021.105393.
     PubMed     Abstract available
     
     
     
142. WESTON LJ, Cook ZT, Stackhouse TL, Sal MK, et al
     In vivo aggregation of presynaptic alpha-synuclein is not influenced by its phosphorylation at serine-129.
     Neurobiol Dis. 2021;152:105291.
     PubMed     Abstract available
     
     
     
143. WIEST C, Tinkhauser G, Pogosyan A, He S, et al
     Subthalamic deep brain stimulation induces finely-tuned gamma oscillations in the absence of levodopa.
     Neurobiol Dis. 2021;152:105287.
     PubMed     Abstract available
     
     
     April 2021
144. YIN Z, Zhu G, Zhao B, Bai Y, et al
     Local field potentials in Parkinson's disease: a frequency-based review.
     Neurobiol Dis. 2021 Apr 28:105372. doi: 10.1016/j.nbd.2021.105372.
     PubMed     Abstract available
     
     
     
145. PETERS OM, Weiss A, Metterville J, Song L, et al
     Genetic diversity of axon degenerative mechanisms in models of Parkinson's disease.
     Neurobiol Dis. 2021 Apr 20:105368. doi: 10.1016/j.nbd.2021.105368.
     PubMed     Abstract available
     
     
     March 2021
146. BRUMBERG J, Kuzkina A, Lapa C, Mammadova S, et al
     Dermal and cardiac autonomic fiber involvement in Parkinson's disease and multiple system atrophy.
     Neurobiol Dis. 2021 Mar 12:105332. doi: 10.1016/j.nbd.2021.105332.
     PubMed     Abstract available
     
     
     
147. CHU Y, Kordower JH
     GDNF signaling in subjects with minimal motor deficits and Parkinson's disease.
     Neurobiol Dis. 2021 Mar 5:105298. doi: 10.1016/j.nbd.2021.105298.
     PubMed     Abstract available
     
     
     
148. ZOU L, Zhang X, Xiong M, Meng L, et al
     Asparagine endopeptidase cleaves synaptojanin 1 and triggers synaptic dysfunction in Parkinson's disease.
     Neurobiol Dis. 2021 Mar 4:105326. doi: 10.1016/j.nbd.2021.105326.
     PubMed     Abstract available
     
     
     
149. CREED RB, Roberts RC, Farmer CB, McMahon LL, et al
     Increased glutamate transmission onto dorsal striatum spiny projection neurons in Pink1 knockout rats.
     Neurobiol Dis. 2021;150:105246.
     PubMed     Abstract available
     
     
     February 2021
150. JIANG M, Tu HT, Zhang K, Zhang W, et al
     Impaired neurogenesis in the hippocampus of an adult VPS35 mutant mouse model of Parkinson's disease through interaction with APP.
     Neurobiol Dis. 2021 Feb 23:105313. doi: 10.1016/j.nbd.2021.105313.
     PubMed     Abstract available
     
     
     
151. DE MIRANDA BR, Castro SL, Rocha EM, Bodle CR, et al
     The industrial solvent trichloroethylene induces LRRK2 kinase activity and dopaminergic neurodegeneration in a rat model of Parkinson's disease.
     Neurobiol Dis. 2021 Feb 23:105312. doi: 10.1016/j.nbd.2021.105312.
     PubMed     Abstract available
     
     
     
152. KINNERUP MB, Sommerauer M, Damholdt MF, Schaldemose JL, et al
     Preserved noradrenergic function in Parkinson's disease patients with rest tremor.
     Neurobiol Dis. 2021 Feb 4:105295. doi: 10.1016/j.nbd.2021.105295.
     PubMed     Abstract available
     
     
     January 2021
153. SENCHUK MM, Van Raamsdonk JM, Moore DJ
     Multiple genetic pathways regulating lifespan extension are neuroprotective in a G2019S LRRK2 nematode model of Parkinson's disease.
     Neurobiol Dis. 2021 Jan 12:105267. doi: 10.1016/j.nbd.2021.105267.
     PubMed     Abstract available
     
     
     
154. BLAUWENDRAAT C, Makarious MB, Leonard HL, Bandres-Ciga S, et al
     A population scale analysis of rare SNCA variation in the UK Biobank.
     Neurobiol Dis. 2021;148:105182.
     PubMed     Abstract available
     
     
     
155. ANTONAZZO M, Gomez-Urquijo SM, Ugedo L, Morera-Herreras T, et al
     Dopaminergic denervation impairs cortical motor and associative/limbic information processing through the basal ganglia and its modulation by the CB1 receptor.
     Neurobiol Dis. 2021;148:105214.
     PubMed     Abstract available
     
     
     December 2020
156. YANG J, Luo S, Zhang J, Yu T, et al
     Exosome-mediated delivery of antisense oligonucleotides targeting alpha-synuclein ameliorates the pathology in a mouse model of Parkinson's disease.
     Neurobiol Dis. 2020 Dec 6:105218. doi: 10.1016/j.nbd.2020.105218.
     PubMed     Abstract available
     
     
     November 2020
157. ARASARATNAM CJ, Singh-Bains MK, Waldvogel HJ, Faull RLM, et al
     Neuroimaging and neuropathology studies of X-linked dystonia parkinsonism.
     Neurobiol Dis. 2020;148:105186.
     PubMed     Abstract available
     
     
     
158. AGLIARDI C, Meloni M, Guerini FR, Zanzottera M, et al
     Oligomeric alpha-Syn and SNARE complex proteins in peripheral extracellular vesicles of neural origin are biomarkers for Parkinson's disease.
     Neurobiol Dis. 2020 Nov 17:105185. doi: 10.1016/j.nbd.2020.105185.
     PubMed     Abstract available
     
     
     
159. UNDERWOOD CF, Parr-Brownlie LC
     Primary motor cortex in Parkinson's disease: Functional changes and opportunities for neurostimulation.
     Neurobiol Dis. 2020 Nov 2:105159. doi: 10.1016/j.nbd.2020.105159.
     PubMed     Abstract available
     
     
     October 2020
160. WILKINS KB, Parker JE, Bronte-Stewart HM
     Gait variability is linked to the atrophy of the Nucleus Basalis of Meynert and is resistant to STN DBS in Parkinson's disease.
     Neurobiol Dis. 2020;146:105134.
     PubMed     Abstract available
     
     
     September 2020
161. BAASKE MK, Kormann E, Holt AB, Gulberti A, et al
     Parkinson's disease uncovers an underlying sensitivity of subthalamic nucleus neurons to beta-frequency cortical input in vivo.
     Neurobiol Dis. 2020 Sep 26:105119. doi: 10.1016/j.nbd.2020.105119.
     PubMed     Abstract available
     
     
     June 2020
162. ZHENG C, Xu Y, Chen G, Tan Y, et al
     Distinct anti-dyskinetic effects of amantadine and group II metabotropic glutamate receptor agonist LY354740 in a rodent model: An electrophysiological perspective.
     Neurobiol Dis. 2020;139:104807.
     PubMed     Abstract available
     
     
     
163. PELLEGRINI C, Ippolito C, Segnani C, Dolfi A, et al
     Pathological remodelling of colonic wall following dopaminergic nigrostriatal neurodegeneration.
     Neurobiol Dis. 2020;139:104821.
     PubMed     Abstract available
     
     
     
164. ANAND N, Holcom A, Broussalian M, Schmidt M, et al
     Dysregulated iron metabolism in C. elegans catp-6/ATP13A2 mutant impairs mitochondrial function.
     Neurobiol Dis. 2020;139:104786.
     PubMed     Abstract available
     
     
     May 2020
165. FAUSTINI G, Longhena F, Bruno A, Bono F, et al
     Alpha-synuclein/synapsin III pathological interplay boosts the motor response to methylphenidate.
     Neurobiol Dis. 2020;138:104789.
     PubMed     Abstract available
     
     
     April 2020
166. VINUEZA-GAVILANES R, Inigo-Marco I, Larrea L, Lasa M, et al
     N-terminal acetylation mutants affect alpha-synuclein stability, protein levels and neuronal toxicity.
     Neurobiol Dis. 2020;137:104781.
     PubMed     Abstract available
     
     
     
167. BAASKE MK, Kramer ER, Meka DP, Engler G, et al
     Parkin deficiency perturbs striatal circuit dynamics.
     Neurobiol Dis. 2020;137:104737.
     PubMed     Abstract available
     
     
     February 2020
168. STOYKA LE, Arrant AE, Thrasher DR, Russell DL, et al
     Behavioral defects associated with amygdala and cortical dysfunction in mice with seeded alpha-synuclein inclusions.
     Neurobiol Dis. 2020;134:104708.
     PubMed     Abstract available
     
     
     
169. AFGHAH Z, Chen X, Geiger JD
     Role of endolysosomes and inter-organellar signaling in brain disease.
     Neurobiol Dis. 2020;134:104670.
     PubMed     Abstract available
     
     
     
170. CHEN C, Vincent AE, Blain AP, Smith AL, et al
     Investigation of mitochondrial biogenesis defects in single substantia nigra neurons using post-mortem human tissues.
     Neurobiol Dis. 2020;134:104631.
     PubMed     Abstract available
     
     
     
171. ALBERQUILLA S, Gonzalez-Granillo A, Martin ED, Moratalla R, et al
     Dopamine regulates spine density in striatal projection neurons in a concentration-dependent manner.
     Neurobiol Dis. 2020;134:104666.
     PubMed     Abstract available
     
     
     
172. SOLTI K, Kuan WL, Forizs B, Kustos G, et al
     DJ-1 can form beta-sheet structured aggregates that co-localize with pathological amyloid deposits.
     Neurobiol Dis. 2020;134:104629.
     PubMed     Abstract available
     
     
     
173. YANG SY, Gegg M, Chau D, Schapira A, et al
     Glucocerebrosidase activity, cathepsin D and monomeric alpha-synuclein interactions in a stem cell derived neuronal model of a PD associated GBA1 mutation.
     Neurobiol Dis. 2020;134:104620.
     PubMed     Abstract available
     
     
     
174. MEZIAS C, Rey N, Brundin P, Raj A, et al
     Neural connectivity predicts spreading of alpha-synuclein pathology in fibril-injected mouse models: Involvement of retrograde and anterograde axonal propagation.
     Neurobiol Dis. 2020;134:104623.
     PubMed     Abstract available
     
     
     
175. CRESTO N, Gaillard MC, Gardier C, Gubinelli F, et al
     The C-terminal domain of LRRK2 with the G2019S mutation is sufficient to produce neurodegeneration of dopaminergic neurons in vivo.
     Neurobiol Dis. 2020;134:104614.
     PubMed     Abstract available
     
     

Thank you for your interest in scientific medicine.

AMEDEO Parkinson's Disease is free of charge.